Latest Insider Transactions at Cv Rx, Inc. (CVRX)
This section provides a real-time view of insider transactions for Cv Rx, Inc. (CVRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVRx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVRx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 13
2022
|
Joseph P Slattery |
BUY
Exercise of conversion of derivative security
|
Direct |
11,640
+5.56%
|
$0
$0.32 P/Share
|
|
Dec 30
2021
|
John Brintnall CHIEF STRATEGY OFFICER AND SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,550
+19.62%
|
$0
$0.24 P/Share
|
|
Dec 28
2021
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,080
+13.71%
|
$0
$0.24 P/Share
|
|
Nov 30
2021
|
Joseph P Slattery |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+25.96%
|
$0
$0.24 P/Share
|
|
Nov 24
2021
|
Dean Bruhn Ding VP OF REG. AFFAIRS AND QA |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+41.61%
|
$0
$0.24 P/Share
|
|
Nov 22
2021
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,006
+50.0%
|
$0
$0.24 P/Share
|
|
Nov 19
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
300
+9.68%
|
$3,900
$13.69 P/Share
|
|
Nov 18
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
875
+25.93%
|
$12,250
$14.63 P/Share
|
|
Aug 12
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
625
+27.78%
|
$11,875
$19.72 P/Share
|
|
Jul 02
2021
|
Enterprise Associates 10 L P New > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
225,500
+10.02%
|
$4,059,000
$18.0 P/Share
|
|
Jul 02
2021
|
Enterprise Associates 10 L P New > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,800,583
+31.8%
|
-
|
|
Jul 02
2021
|
Nea Partners 10 L P > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,250
+11.25%
|
$4,504,500
$18.0 P/Share
|
|
Jul 02
2021
|
Nea Partners 10 L P > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,947,837
+32.0%
|
-
|
|
Jul 02
2021
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
275,000
+21.44%
|
$4,950,000
$18.0 P/Share
|
|
Jul 02
2021
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
700,772
+20.84%
|
-
|
|
Jul 02
2021
|
Geoffrey B Pardo Director |
BUY
Open market or private purchase
|
Indirect |
275,000
+13.07%
|
$4,950,000
$18.0 P/Share
|
|
Jul 02
2021
|
Geoffrey B Pardo Director |
BUY
Conversion of derivative security
|
Indirect |
1,554,022
+50.0%
|
-
|
|
Jul 02
2021
|
Kirk G. Nielsen |
BUY
Conversion of derivative security
|
Indirect |
1,461,831
+50.0%
|
-
|
|
Jul 02
2021
|
Joseph P Slattery |
BUY
Grant, award, or other acquisition
|
Direct |
5,555
+50.0%
|
$99,990
$18.0 P/Share
|
|
Jul 02
2021
|
John Brintnall CHIEF STRATEGY OFFICER AND SEC |
BUY
Conversion of derivative security
|
Direct |
7,900
+45.87%
|
-
|
|
Jul 02
2021
|
Johnson & Johnson |
BUY
Conversion of derivative security
|
Indirect |
3,495,575
+50.0%
|
-
|
|
Jul 02
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Indirect |
222,222
+19.23%
|
$3,999,996
$18.0 P/Share
|
|
Jul 02
2021
|
Mudit K. Jain |
BUY
Conversion of derivative security
|
Indirect |
711,161
+50.0%
|
-
|
|
Jul 02
2021
|
John M Nehra |
BUY
Open market or private purchase
|
Direct |
27,777
+49.56%
|
$499,986
$18.0 P/Share
|
|
Jul 01
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$25,000
$25.1 P/Share
|
|
Jul 01
2021
|
John M Nehra |
BUY
Open market or private purchase
|
Indirect |
50
+33.33%
|
$1,250
$25.8 P/Share
|
|
Jun 30
2021
|
John M Nehra |
BUY
Open market or private purchase
|
Indirect |
50
+50.0%
|
$1,350
$27.43 P/Share
|